Versant Venture Management
Latest statistics and disclosures from Versant Venture Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are CRSP, CTNM, RPTX, SKYE, Adverum Biotechnologies, and represent 96.75% of Versant Venture Management's stock portfolio.
- Reduced shares in these 2 stocks: PASG, ALGS.
- Sold out of its positions in ALGS, PASG.
- Versant Venture Management was a net seller of stock by $-3.7M.
- Versant Venture Management has $64M in assets under management (AUM), dropping by -17.75%.
- Central Index Key (CIK): 0001560009
Tip: Access up to 7 years of quarterly data
Positions held by Versant Venture Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Versant Venture Management
Versant Venture Management holds 6 positions in its portfolio as reported in the September 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| CRISPR Therapeutics Common Shares (CRSP) | 36.8 | $23M | 499k | 46.98 |
|
|
| Contineum Therapeutics Common Stock (CTNM) | 27.6 | $18M | 918k | 19.14 |
|
|
| Repare Therapeutics Common Stock (RPTX) | 14.3 | $9.1M | 2.6M | 3.44 |
|
|
| Skye Bioscience Common Stock (SKYE) | 12.3 | $7.9M | 2.0M | 3.91 |
|
|
| Adverum Biotechnologies Common Stock | 5.6 | $3.6M | 507k | 7.02 |
|
|
| Gritstone Oncology Common Stock (GRTS) | 3.2 | $2.1M | 3.6M | 0.58 |
|
Past Filings by Versant Venture Management
SEC 13F filings are viewable for Versant Venture Management going back to 2014
- Versant Venture Management 2024 Q3 filed Nov. 8, 2024
- Versant Venture Management 2024 Q2 filed Aug. 7, 2024
- Versant Venture Management 2024 Q1 filed May 3, 2024
- Versant Venture Management 2023 Q4 filed Feb. 8, 2024
- Versant Venture Management 2023 Q3 filed Nov. 3, 2023
- Versant Venture Management 2023 Q2 filed Aug. 9, 2023
- Versant Venture Management 2023 Q1 filed May 11, 2023
- Versant Venture Management 2022 Q4 filed Feb. 9, 2023
- Versant Venture Management 2022 Q3 filed Nov. 10, 2022
- Versant Venture Management 2022 Q2 filed Aug. 11, 2022
- Versant Venture Management 2022 Q1 filed May 10, 2022
- Versant Venture Management 2021 Q4 filed Feb. 11, 2022
- Versant Venture Management 2021 Q3 filed Nov. 12, 2021
- Versant Venture Management 2021 Q2 filed Aug. 12, 2021
- Versant Venture Management 2021 Q1 filed May 7, 2021
- Versant Venture Management 2020 Q4 filed Feb. 16, 2021